Variant report
Variant | nsv963963 |
---|---|
Chromosome Location | chr2:126211293-126248142 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CNTNAP5-9 | chr2:126239624-126239889 | NONHSAT074116 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150150675 | chr2:126212203-126212204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534318999 | chr2:126212270-126212271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374446450 | chr2:126212282-126212283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373450709 | chr2:126212339-126212340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13389438 | chr2:126212344-126212345 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs551052826 | chr2:126212401-126212402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11897289 | chr2:126212403-126212404 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs372496658 | chr2:126212409-126212410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545285196 | chr2:126212447-126212448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565037767 | chr2:126212452-126212453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191106917 | chr2:126212469-126212470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538333035 | chr2:126212486-126212487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145619649 | chr2:126212509-126212510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182567209 | chr2:126212522-126212523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536408698 | chr2:126212524-126212525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148903389 | chr2:126212538-126212539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529724755 | chr2:126212539-126212540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186982940 | chr2:126212547-126212548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560089661 | chr2:126212552-126212553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532012398 | chr2:126212606-126212607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10171503 | chr2:126212613-126212614 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs569583787 | chr2:126212634-126212635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538416106 | chr2:126212665-126212666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78205388 | chr2:126212808-126212809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568707459 | chr2:126212856-126212857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535840434 | chr2:126212873-126212874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534281381 | chr2:126212894-126212895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554021515 | chr2:126212938-126212939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10171912 | chr2:126213027-126213028 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs538563574 | chr2:126213029-126213030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539459896 | chr2:126213034-126213035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558782160 | chr2:126213035-126213036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575173764 | chr2:126213052-126213053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12470142 | chr2:126213065-126213066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574206054 | chr2:126213109-126213110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544133877 | chr2:126213112-126213113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192298464 | chr2:126213118-126213119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560738599 | chr2:126213128-126213129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574338185 | chr2:126213156-126213157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34709031 | chr2:126213169-126213170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200816869 | chr2:126213176-126213177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541692666 | chr2:126213180-126213181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371074806 | chr2:126213248-126213249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575155107 | chr2:126213258-126213259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12466744 | chr2:126213265-126213266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs532094291 | chr2:126213297-126213298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551905499 | chr2:126213320-126213321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554638587 | chr2:126213340-126213341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562498202 | chr2:126213361-126213362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532029815 | chr2:126213368-126213369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:126212200-126215200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr2:126212400-126213200 | Enhancers | GM12878-XiMat | blood |
3 | chr2:126212600-126213200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr2:126213800-126214000 | Enhancers | Fetal Brain Male | brain |
5 | chr2:126214000-126215000 | Weak transcription | Fetal Brain Male | brain |
6 | chr2:126215000-126215600 | Enhancers | Fetal Brain Male | brain |
7 | chr2:126224400-126224800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr2:126224800-126227400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr2:126227400-126227600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr2:126229400-126229800 | Enhancers | A549 | lung |
11 | chr2:126229600-126229800 | Flanking Bivalent TSS/Enh | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr2:126234000-126234600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr2:126236400-126237400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr2:126236600-126237200 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
15 | chr2:126236600-126237200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |